PETS

PetMed Express Celebrates National Pet Day: On April 11, 2025, PetMed Express will ring the Nasdaq Opening Bell to honor National Pet Day, featuring adoptable rescue dogs and emphasizing the bond between pets and their owners.

Commitment to Pet Welfare: PetMed Express promotes pet adoption and wellness through its services, providing essential healthcare products for pets while encouraging pet lovers to share their rescue stories on social media.

New Board Appointment: PetMed Express, Inc. has appointed Peter Batushansky to its Board of Directors, bringing over 20 years of experience in retail, pet healthcare, and private equity, while longtime board member Dr. Gian Fulgoni plans to retire.

Leadership Transformation: The appointment is part of a broader leadership transformation strategy aimed at enhancing shareholder value, with several new directors joining the Board since 2024 to align skills with the company's growth objectives.

Progressive Stock Analysis: The Progressive Corporation (PGR) is highlighted as a strong investment choice due to its low volatility, consistent earnings growth, and favorable Zacks Rank #1. Analysts have raised earnings estimates significantly, indicating robust performance and stability in a challenging market.

PetMed Express Challenges: PetMed Express (PETS) faces declining sales and earnings, with analysts consistently lowering forecasts, leading to a Zacks Rank #5 (Strong Sell). Despite being positioned in a growing pet care market, the company's inability to maintain momentum raises concerns about its long-term viability.

Company Performance: PetMed Express (PETS) is experiencing a significant decline in sales and earnings, with analysts projecting continued revenue drops of 18.6% this year and 6.8% next year, leading to a Zacks Rank #5 (Strong Sell) rating.

Valuation Concerns: Despite its struggles, PETS trades at a high valuation of 21.1x forward earnings, which appears unjustifiable given its deteriorating fundamentals, making it an unattractive investment option until the company can stabilize its performance.

Market Movers: Lipella Pharmaceuticals surged 50% after positive trial results, while Vast Renewables and Lifeward saw increases of 30% and 10%, respectively. Conversely, PetMed Express and Fluence Energy experienced significant declines following earnings reports.

Earnings Impact: Lattice Semiconductor and SelectQuote reported gains of 15% and 31% post-earnings, while several companies, including Harmonic and Marriott, faced losses after their earnings announcements.

Stock Performance Overview: SelectQuote, Lattice Semiconductor, and Radiant Logistics saw significant gains after earnings reports, while Fluence Energy and Harmonic experienced substantial declines.

Market Insights: TipRanks' Smart Score tool is highlighted as a resource for investors to track stock performance and compare with Wall Street analysts' recommendations.

Q3 Financial Performance: Petmed Express reported Q3 revenue of $52.98 million, down from $65.32 million last year, but achieved a $2 million Adjusted EBITDA, improving by $1.1 million year-over-year while reducing G&A expenses by $2.6 million.

CEO's Statement on Transformation: CEO Sandra Campos highlighted significant progress in the company's transformation journey, emphasizing their commitment to operational excellence, sustainable growth, and increased shareholder value.

Management Insights: PetMed Express reported a Q3 2025 net loss of $700,000, showing improvement from the previous year, while achieving $2 million in adjusted EBITDA and implementing strategic initiatives to enhance customer experience and optimize inventory.

Financial Outlook: Despite a 19% decline in net sales due to reduced advertising spend, management remains optimistic about long-term growth through cost management, digital transformation, and targeting younger demographics.

Major Earnings Announcements: Vertex Pharmaceuticals, Prospect Capital Corporation, Apollo Commercial Real Estate Finance, and PennantPark Floating Rate Capital are among the key companies expected to report earnings after the market closes on Monday.

Additional Earnings Releases: A variety of other companies, including ACGL, ALAB, AMKR, and COTY, are also scheduled to release their earnings following Monday's market close.

Marathon Petroleum Insider Buying: Jeffrey C. Campbell purchased 6,000 shares of Marathon Petroleum at $149.61 each, totaling $897,644, and is currently up about 4.1% as the stock trades higher.

PetMed Express Insider Buying: Director Leslie C.G. Campbell bought 60,000 shares of PetMed Express for $5.41 each, amounting to $324,636, with a current gain of approximately 26.6% as the stock rises significantly.

PetMeds Adopts Shareholder Rights Plan: PetMed Express, Inc. has implemented a limited duration shareholder rights plan to protect its shareholders' interests amid significant stock accumulations and to ensure that the company's shares reflect their inherent value.

Rights Plan Details: The plan allows shareholders to purchase additional shares at a discount if an acquiring entity gains control of 12.5% or more of the company without board approval, and it will be effective until December 2, 2025.

Ordergroove and PetMed Express Partnership: Ordergroove has partnered with PetMed Express to enhance their subscription and membership services, aiming to improve operational efficiency and customer experience through advanced technology features like prepaid subscriptions and personalized promotions.

Impact on Pet Care Services: This collaboration is expected to redefine how pet owners manage their pets' health needs by providing a more personalized and streamlined subscription experience, ultimately increasing customer satisfaction and retention.

Appointment of New CFO: PetMed Express, Inc. has appointed Robyn D'Elia as Chief Financial Officer effective September 16, 2024. D'Elia brings over 25 years of financial leadership experience, including significant roles at Bed Bath & Beyond and most recently as CFO at Odeko.

Company's Vision for Growth: President and CEO Sandra Campos expressed excitement about D'Elia's appointment, highlighting her expertise in financial discipline and operational rigor, which aligns with the company's goals for expansion and long-term shareholder value.

Conference Call Announcement: PetMed Express Inc. will hold a conference call on August 6, 2024, at 4:30 PM ET to discuss its Q1 25 earnings results.

Access Information: The call can be accessed via a live webcast or by phone, with specific numbers provided for both US and international listeners.

New Appointment: PetMed Express, Inc. has appointed Doug Krulik as Chief Accounting Officer effective August 19, 2024, bringing over 20 years of finance and accounting experience to the role.

Company Growth Focus: Krulik's appointment aligns with PetMeds' initiatives to enhance operational excellence and financial governance, emphasizing a commitment to improving accounting processes and driving growth.